Delivery Order SPE2DB22D9311-SPE2DB25FP6XB

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with a ceiling value of $1,968.40 and a performance period through March 14, 2024. The contract is a firm fixed-price delivery order, which means DLA can issue orders against this contract for a variety of pharmaceutical items to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,115.64 firm-fixed-price contract is for the supply of the pharmaceutical product "ENGERIX-B 20 MCG/ML SYRNML" with a completion date of June 18, 2024. The award is under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business located in Park Ridge, Illinois. The $7,873.60 order is for ENGERIX-B 20 MCG/ML syringes and is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract with DLA under the SPE2DB program. This IDV enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with a potential value of $3,120.64 and a completion date of December 12, 2023. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency, with a potential...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a vaccine product, with a potential value of $1,560.32. The period of performance runs through May 4, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds numerous federal contracts and Indefinite Delivery Vehicles (IDVs) to supply a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Engerix-B 20 MCG/ML syringes, with a total ceiling value of $37,559.88 and a performance period through June 14, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN. The order has a potential value of $1,119.33 and a completion date of August 11, 2022. This delivery order is part of a larger indefinite delivery contract with DMS Pharmaceutical Group to supply a variety of pharmaceutical and medical products to military treatment facilities worldwide, with a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,668.88 firm fixed-price contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA, valued at up to...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN for a potential value of $3,731.10. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities worldwide. The contract does not...
This federal contract award, valued at $5,905.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with an ultimate completion date of October 29, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 with...
  • SPE2DB22D9311
    Indefinite Delivery Contract
  • SPE2DB22D9311-SPE2DB25FP6XB
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,642.71 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 4/30/25, 10:24 AM